Diagnosis and management of the primary headache disorders in the emergency department setting.
Headache continues to be a frequent cause of emergency department (ED) use, accounting for 2% of all visits. Most of these headaches prove to be benign but painful exacerbations of chronic headache disorders, such as migraine, tension-type, and cluster. The goal of ED management is to provide rapid and quick relief of benign headache, without causing undue side effects, and to recognize headaches with malignant course. Although these headaches have distinct epidemiologies and clinical phenotypes, there is overlapping response to therapy; nonsteroidals, triptans, dihydroergotamine, and the antiemetic dopamine antagonists may play a therapeutic role for each of these acute headaches. This article reviews the diagnostic criteria and management strategies for the primary headache disorders.
Friedman
Benjamin Wolkin
BW
Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10467, USA. befriedm@montefiore.org
Grosberg
Brian Mitchell
BM
D000701:Analgesics, Opioid / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000927:Anticonvulsants / Q000627:therapeutic use; D004087:Dihydroergotamine / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000627:therapeutic use; D004636:Emergency Service, Hospital; D020773:Headache Disorders / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology; D006300:Health Services Misuse; D006801:Humans; D010343:Patient Admission; D010351:Patient Discharge; D012008:Recurrence; D014363:Tryptamines / Q000627:therapeutic use; D014635:Valproic Acid
D000701:Analgesics, Opioid; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000927:Anticonvulsants; D018491:Dopamine Agonists; D014363:Tryptamines; D004087:Dihydroergotamine; D014635:Valproic Acid